Xencor | Spese Operative



Operating Expenses Cambiamento Data
AbbVie USD 9.61B 6.98B 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amgen USD 6.86B 85M 2025-03
Arrowhead Research USD 161.51M 2.4M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Biogen USD 2.12B 106.5M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Cytokinetics USD 157.21M 1.24M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
J&J USD 8.26B 10.37B 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Xencor USD 75.91M 9.94M 2025-03



Xencor Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.